The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trials. Transitioning to and from the novel oral anticoagulants: a management strategy for clinicians. Rodent carcinogenicity as a case study. Journal of thrombosis and thrombolysis, 52 4, 1010-1019, Blumer, Vanessa; Rivera, Manuel; Corbaln, Ramn; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Piccini, Jonathan P; Hellkamp, Anne S; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R 2021. The potential roles of Von Willebrand factor and neutrophil extracellular traps in the natural history of hypertrophic and hypertensive cardiomyopathy. Cardiovascular Risk Factors and Target Organ Damage in Adolescents: The SHIP AHOY Study. European heart journal, 35 47, 3377-85, Daly, Patrick L; Becker, Richard C 2014. Pathologist Richard Ablin . Journal of thrombosis and thrombolysis, 52 2, 408-413, Samman, Karla N; Mehanna, Pamela; Takla, Emad; Grenier, Jean-Christophe; Chan, Mark Y; Lopes, Renato D; Neely, Megan Lee; Wang, Tracy Y; Newby, L Kristin; Becker, Richard C; Lordkipanidz, Marie; Ruiz, Matthieu; Hussin, Julie G; Jolicur, E Marc 2021. Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence. Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. In 2012, Dr. Richard Garza, Radiation Oncologist, joined the ACFRO team bringing his expertise in the treatment of prostate cancer. Fax: 513-558-2884 Journal of thrombosis and thrombolysis, 44 2, 145-153, Nimjee, Shahid M; White, Rebekah R; Becker, Richard C; Sullenger, Bruce A 2017. Circulation, 105 20, 2385-91, Harrold, Leslie R; Gurwitz, Jerry H; Tate, Janet P; Becker, Richard; Stuart, Tammy; Elwell, Anne; Radford, Martha 2002. Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Prostate cancer may get a lot of press, but consider the numbers . The first brazen lies about prostate cancer surgery. Relevance weighting of tier 1 endocrine screening endpoints by rank order. Bazrafshan, Sholeh; Kushlaf, Hani; Kakroo, Mashhood; Quinlan, John; Becker, Richard C; Sadayappan, Sakthivel 2021. European heart journal. North American Thrombosis Forum, AF Action Initiative Consensus Document. European heart journal, 34 31, 2481-9. Dr. Becker's office is located at Report of an ISRTP Workshop: Progress and barriers to incorporating alternative toxicological methods in the U.S. Richard A. Becker, Christopher J. Borgert, Simon Webb, Jay Ansell, Sara Amundson, Christopher J. Portier, Alan M. Goldberg, L.H. Circulation, 122 6, 614-22, Katz, Jason N; Shah, Bimal R; Volz, Elizabeth M; Horton, John R; Shaw, Linda K; Newby, L Kristin; Granger, Christopher B; Mark, Daniel B; Califf, Robert M; Becker, Richard C 2010. Coronavirus COVID-19 Updates: uc.edu/publichealth, University of CincinnatiDepartment of Internal Medicine Isotopes of nitrogen on Mars: Atmospheric measurements by?Curiosity's mass spectrometer. Journal of thrombosis and thrombolysis, 48 1, 14-26, Nimjee, Shahid M; Dornbos, David; Pitoc, George A; Wheeler, Debra G; Layzer, Juliana M; Venetos, Nicholas; Huttinger, Allyson; Talentino, Spencer E; Musgrave, Nicholas J; Moody, Holly; Rempel, Rachel E; Jones, Cheyenne; Carlisle, Kendyl; Wilson, Jenna; Bratton, Camille; Joseph, Matthew E; Khan, Shoeb; Hoffman, Maureane R; Sommerville, Laura; Becker, Richard C; Zweier, Jay L; Sullenger, Bruce A 2019. Thrombosis research, 192 , 78-87, Becker, Richard C; Sadayappan, Sakthivel 2020. Journal of thrombosis and thrombolysis, 32 2, 242-66, Povsic, Thomas J; Cohen, Mauricio G; Mehran, Roxana; Buller, Christopher E; Bode, Christoph; Cornel, Jan H; Kasprzak, Jaros?aw D; Montalescot, Gilles; Joseph, Diane; Wargin, William A; Rusconi, Christopher P; Zelenkofske, Steven L; Becker, Richard C; Alexander, John H 2011. Men who had surgery had . Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors. Frontiers in physiology, 11 , 608473, Olivotto, Iacopo; Oreziak, Artur; Barriales-Villa, Roberto; Abraham, Theodore P; Masri, Ahmad; Garcia-Pavia, Pablo; Saberi, Sara; Lakdawala, Neal K; Wheeler, Matthew T; Owens, Anjali; Kubanek, Milos; Wojakowski, Wojciech; Jensen, Morten K; Gimeno-Blanes, Juan; Afshar, Kia; Myers, Jonathan; Hegde, Sheila M; Solomon, Scott D; Sehnert, Amy J; Zhang, David; Li, Wanying; Bhattacharya, Mondira; Edelberg, Jay M; Waldman, Cynthia Burstein; Lester, Steven J; Wang, Andrew; Ho, Carolyn Y; Jacoby, Daniel 2020. Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements. Radiosurgery offers great appeal: focused treatment allowing greater dose in fewer sessions [] Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Hypertension (Dallas, Tex. Chest, 133 6 Suppl, 299S-339S, Lohrmann, Jens; Becker, Richard C 2008. : 1979), 77 6, 1857-1866, Ugowe, Francis E; Hellkamp, Anne S; Wang, Allen; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Patel, Manesh R; Piccini, Jonathan P 2021. The Journal of allergy and clinical immunology, 138 6, 1712-1715, Ruff, Christian T; Ansell, Jack E; Becker, Richard C; Benjamin, Emelia J; Deicicchi, David J; Mark Estes, N A; Ezekowitz, Michael D; Fanikos, John; Fareed, Jawed; Garcia, David; Giugliano, Robert P; Goldhaber, Samuel Z; Granger, Christopher; Healey, Jeff S; Hull, Russell; Hylek, Elaine M; Libby, Peter; Lopes, Renato D; Mahaffey, Kenneth W; Mega, Jessica; Piazza, Gregory; Sasahara, Arthur A; Sorond, Farzaneh A; Spyropoulos, Alex C; Walenga, Jeanine M; Weitz, Jeffrey I 2016. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial. : 1979), 75 6, 1551-1556, Ueland, Thor; kerblom, Axel; Ghukasyan, Tatevik; Michelsen, Annika E; Becker, Richard C; Bertilsson, Maria; Budaj, Andrzej; Cornel, Jan H; Himmelmann, Anders; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Aukrust, Pl; Wallentin, Lars 2020. Catheter thrombosis and percutaneous coronary intervention: fundamental perspectives on blood, artificial surfaces and antithrombotic drugs. Clasen, R. A., Hartmann, J. F., Coogan, P. S., Pandolfi, S., Laing, I., Becker, R. A. See all conditions on Dr. Becker's, Best Hospitals for Diabetes & Endocrinology, Lilly Plans to Slash Some Insulin Prices, Expand Cost Cap. Journal of thrombosis and thrombolysis, 50 1, 43-53, Becker, Richard C 2020. COVID-19-associated vasculitis and vasculopathy. Hagstrm, Emil; James, Stefan K; Bertilsson, Maria; Becker, Richard C; Himmelmann, Anders; Husted, Steen; Katus, Hugo A; Steg, Philippe Gabriel; Storey, Robert F; Siegbahn, Agneta; Wallentin, Lars 2015. Journal of thrombosis and thrombolysis, , Becker, Richard C; Helmy, Tarek 2015. Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitor. Hypertension (Dallas, Tex. Each year, UroPartners joins forces with a nonprofit organization to host the community prostate cancer awareness event, SEA Blue. Journal of thrombosis and thrombolysis, 32 1, 9-20, Xu, Weixian; Wang, Tracy Y; Becker, Richard C 2011. Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity. Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban. Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study. Journal of thrombosis and thrombolysis, 23 2, 159-61, Gurbel, Paul A; Becker, Richard C; Mann, Kenneth G; Steinhubl, Steven R; Michelson, Alan D 2007. Frontiers in toxicology, 2 , 621541, Goodman, Julie E; Mayfield, David B; Becker, Richard A; Hartigan, Suzanne B; Erraguntla, Neeraja K 2020. The American journal of cardiology, 108 11, 1542-6, Woodruff, Rebecca S; Sullenger, Bruce; Becker, Richard C 2011. Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine. Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. . Moving Up the Coagulation Cascade: Potential Factor X Inhibition for Percutaneous Coronary Intervention. Whom better to ask, because during that time he and Cindy immersed themself in the world of natural healing and today his cancer is still in . Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease. The New England journal of medicine, 358 26, 2827-9, Becker, Richard C 2007. Patients seeking routine and specialized urological care will have access to the most advanced equipment and services available. Antiplatelet therapy in prevention of cardio- and venous thromboembolic events. Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence. Dr. Richard Becker, MD is a endocrinology, diabetes & metabolism specialist in San Antonio, TX. 'Your Health' with Dr. Richard and Cindy Becker Show. Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial. Lorenz R. Rhomberg, Julie E. Goodman, Lisa A. Bailey, Robyn L. Prueitt, Nancy B. Beck, Christopher Bevan, Michael Honeycutt, Norbert E. Kaminski, Greg Paoli, Lynn H. Pottenger, Roberta W. Scherer, Kimberly Wise, Richard A. Becker, Advancing human health risk assessment: Integrating recent advisory committee recommendations, Michael L. Dourson, Richard A. Becker, Lynne T. Haber, Lynn H. Pottenger, Tiffany Bredfeldt, Penelope A. Fenner-Crisp. Discrepancies in the primary PLATO trial publication and the FDA reviews, International Journal of Cardiology, 2014. International journal of cardiology, , Wallentin, Lars; Becker, Richard C; Cannon, Christopher P; Held, Claes; Himmelmann, Anders; Husted, Steen; James, Stefan K; Katus, Hugo S; Mahaffey, Kenneth W; Pieper, Karen S; Storey, Robert F; Steg, Philippe Gabriel; Harrington, Robert A 2014. Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013. International journal of cardiology, 170 3, e59-62, Wallentin, Lars; Lindholm, Daniel; Siegbahn, Agneta; Wernroth, Lisa; Becker, Richard C; Cannon, Christopher P; Cornel, Jan H; Himmelmann, Anders; Giannitsis, Evangelos; Harrington, Robert A; Held, Claes; Husted, Steen; Katus, Hugo A; Mahaffey, Kenneth W; Steg, Ph Gabriel; Storey, Robert F; James, Stefan K 2014. The Science of the total environment, 724 , 138004. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Rusyn, Ivan; Sakolish, Courtney; Kato, Yuki; Stephan, Clifford; Vergara, Leoncio; Hewitt, Philip; Bhaskaran, Vasanthi; Davis, Myrtle; Hardwick, Rhiannon; Ferguson, Stephen S; Stanko, Jason P; Bajaj, Piyush; Adkins, Karissa; Sipes, Nisha S; Hunter, Sid; Baltazar, Maria T; Carmichael, Paul L; Sadh, Kritika; Becker, Richard A 2022. Endocrinologists treat disorders of the hormone-secreting glands that regulate countless body functions. Hospital affiliations include Yale New Haven Hospital. Journal of thrombosis and haemostasis : JTH, 7 11, 1759-66, Smyth, Susan S; Woulfe, Donna S; Weitz, Jeffrey I; Gachet, Christian; Conley, Pamela B; Goodman, Shaun G; Roe, Matthew T; Kuliopulos, Athan; Moliterno, David J; French, Patricia A; Steinhubl, Steven R; Becker, Richard C 2009. Richard Becker, MD. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. American heart journal, 179 , 77-86, Sherwood, Matthew W; Cyr, Derek D; Jones, W Schuyler; Becker, Richard C; Berkowitz, Scott D; Washam, Jeffrey B; Breithardt, Gnter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Singer, Daniel E; Piccini, Jonathan P; Nessel, Christopher C; Mahaffey, Kenneth W; Patel, Manesh R 2016. Reports have shown that -glucans exert multiple effects on cancer cells and cancer prevention. Lancet, 376 9749, 1320-8, Williams, Marlene S; Weiss, Ethan J; Sabatine, Marc S; Simon, Daniel I; Bahou, Wadie F; Becker, Lewis C; Parise, Leslie V; Dauerman, Harold L; French, Patricia A; Smyth, Susan S; Becker, Richard C 2010. Languages: English. 10:00 am. Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy). Critical care medicine, 38 2, 375-81, Krishnan, Anandi; Lopes, Renato D; Alexander, John H; Becker, Richard C; Goldstein, Larry B 2010. The pharmacogenetics of antiplatelet agents: towards personalized therapy? Introduction to the American Heart Association's Hypertension Strategically Focused Research Network. Circulation, 135 10, 1001-1003, Lowenstern, Angela; Storey, Robert F; Neely, Megan; Sun, Jie-Lena; Angiolillo, Dominick J; Cannon, Christopher P; Himmelmann, Anders; Huber, Kurt; James, Stefan K; Katus, Hugo A; Morais, Joao; Siegbahn, Agneta; Steg, Phillippe Gabriel; Wallentin, Lars; Becker, Richard C 2017. Factor Xa inhibitors: critical considerations for clinical development and testing. Provides clear information and answers questions in a way patients understand. Reversal of Antithrombotic Therapy: Is it Necessary and Sufficient? Factor IXa as a target for anticoagulation in thrombotic disorders and conditions. 12 april 2022 . This specialist diagnoses and treats cancers that affect the urinary tract and male reproductive organs. academyimpossible twitch bot. Circulation, 130 2, 138-46, Hankey, Graeme J; Stevens, Susanna R; Piccini, Jonathan P; Lokhnygina, Yuliya; Mahaffey, Kenneth W; Halperin, Jonathan L; Patel, Manesh R; Breithardt, Gnter; Singer, Daniel E; Becker, Richard C; Berkowitz, Scott D; Paolini, John F; Nessel, Christopher C; Hacke, Werner; Fox, Keith A A; Califf, Robert M 2014. Hypertension (Dallas, Tex. Methods in molecular biology (Clifton, N.J.), 2379 , 265-276, Eckman, Mark H; Wise, Ruth; Knochelmann, Carol; Mardis, Rachael; Wright, Sharon; Gummadi, Ashish; Dixon, Estrelita; Becker, Richard; Schauer, Daniel P; Flaherty, Matthew L; Costea, Alexandru; Kleindorfer, Dawn; Ireton, Rob; Baker, Pete; Harnett, Brett M; Adejare, Adeboye; Leonard, Anthony C; Sucharew, Heidi; Costanzo, Amy; Arduser, Lora; Kues, John 2022. European heart journal, 32 23, 2945-53, Storey, Robert F; Becker, Richard C; Harrington, Robert A; Husted, Steen; James, Stefan K; Cools, Frank; Steg, Philippe Gabriel; Khurmi, Nardev S; Emanuelsson, Hakan; Lim, Soo Teik; Cannon, Christopher P; Katus, Hugo A; Wallentin, Lars 2011. Toward the Development and Application of an Environmental Risk Assessment Framework for Microplastic. Anticoagulants: Pharmacokinetics, Mechanisms of Action, and Indications. Measurement tools and antidotes for non-vitamin K oral anticoagulants. Annals of internal medicine, 158 12, 861-8. Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF. Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study. Watchlist. 2000 -2011. Journal of the American Heart Association, 2 1, e000031, Berger, Jeffrey S; Becker, Richard C; Kuhn, Cynthia; Helms, Michael J; Ortel, Thomas L; Williams, Redford 2013. International journal of cardiology, 257 , 78-83, Becker, Richard C 2018. ALTEX, 36 4, 523-534, Andersen, Thomas; Ueland, Thor; Ghukasyan Lakic, Tatevik; kerblom, Axel; Bertilsson, Maria; Aukrust, Pl; Michelsen, Annika E; James, Stefan K; Becker, Richard C; Storey, Robert F; Wallentin, Lars; Siegbahn, Agneta; Kontny, Frederic 2019. Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF. New study suggests a drop in screening may have played a role. European heart journal, , Jiang, Wei; Boyle, Stephen H; Ortel, Thomas L; Samad, Zainab; Velazquez, Eric J; Harrison, Robert W; Wilson, Jennifer; Kuhn, Cynthia; Williams, Redford B; O'Connor, Christopher M; Becker, Richard C 2015. Becker, Richard; Grner, Christian; Reichman, Pavel; Dissmeyer, Nico 2022. Brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism is associated with disease severity and incidence of cardiovascular events in a patient cohort. Dr. Richard Becker, MD is an Internal Medicine Specialist in Cincinnati, OH and has over 41 years of experience in the medical field. 28, 2023, Lisa Esposito and Elaine K. HowleyFeb. Journal of thrombosis and thrombolysis, 52 4, 983-984, Becker, Richard C; Sexton, Travis; Smyth, Susan 2021. Revista espaola de cardiologa (English ed. Evaluating management options to reduce Lake Erie algal blooms using an ensemble of watershed models. Stay protected and up-to-date with the latest information. Molecular therapy : the journal of the American Society of Gene Therapy, 27 7, 1228-1241, Parker, William A E; Eriksson, Niclas; Becker, Richard C; Voora, Deepak; kerblom, Axel; Himmelmann, Anders; James, Stefan K; Wallentin, Lars; Storey, Robert F 2019. Modernizing problem formulation for risk assessment necessitates articulation of mode of action. European heart journal. Viewers phone in questions regarding health and well-being. Circulation, 134 1, 37-47, Johansson, sa; Eriksson, Niclas; Lindholm, Daniel; Varenhorst, Christoph; James, Stefan; Syvnen, Ann-Christine; Axelsson, Tomas; Siegbahn, Agneta; Barratt, Bryan J; Becker, Richard C; Himmelmann, Anders; Katus, Hugo A; Steg, Philippe Gabriel; Storey, Robert F; Wallentin, Lars 2016. Preparing for your first cancer appointment can be overwhelming. Lincoff, A Michael; Mehran, Roxana; Povsic, Thomas J; Zelenkofske, Steven L; Huang, Zhen; Armstrong, Paul W; Steg, P Gabriel; Bode, Christoph; Cohen, Mauricio G; Buller, Christopher; Laanmets, Peep; Valgimigli, Marco; Marandi, Toomas; Fridrich, Viliam; Cantor, Warren J; Merkely, Bela; Lopez-Sendon, Jose; Cornel, Jan H; Kasprzak, Jaroslaw D; Aschermann, Michael; Guetta, Victor; Morais, Joao; Sinnaeve, Peter R; Huber, Kurt; Stables, Rod; Sellers, Mary Ann; Borgman, Marilyn; Glenn, Lauren; Levinson, Arnold I; Lopes, Renato D; Hasselblad, Vic; Becker, Richard C; Alexander, John H 2015. Let us know if this information is out of date or incorrect. [3] Only 46 men treated with either surgery or radiation for . This activation triggers the responses of adaptive immune cells such as CD4 (+) or CD8 (+) T cells and B cells, resulting in the inhibition of tumor growth and metastasis. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). Thrombosis research, 156 , 184-190, Washam, Jeffrey B; Hellkamp, Anne S; Lokhnygina, Yuliya; Piccini, Jonathan P; Berkowitz, Scott D; Nessel, Christopher C; Becker, Richard C; Breithardt, Gnter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Singer, Daniel E; Patel, Manesh R 2017. He utilizes his expertise in immunotherapy to advance treatment options. Journal of the American College of Cardiology, , Singer, Daniel E; Hellkamp, Anne S; Piccini, Jonathan P; Mahaffey, Kenneth W; Lokhnygina, Yuliya; Pan, Guohua; Halperin, Jonathan L; Becker, Richard C; Breithardt, Gnter; Hankey, Graeme J; Hacke, Werner; Nessel, Christopher C; Patel, Manesh R; Califf, Robert M; Fox, Keith A A 2013. European journal of preventive cardiology, , Patlewicz, Grace; Ball, Nicholas; Becker, Richard A; Booth, Ewan D; Cronin, Mark T D; Kroese, Dinant; Steup, David; van Ravenzwaay, Ben; Hartung, Thomas 2014. You lie on a table where a device delivers the radiation for five to 10 minutes. Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial). Heart rhythm : the official journal of the Heart Rhythm Society, 11 6, 925-32, Steinhubl, Steven R; Eikelboom, John W; Hylek, Elaine M; Dauerman, Harold L; Smyth, Susan S; Becker, Richard C 2014. Derivation of a No-significant-risk-level (NSRL) for dermal exposures to diethanolamine. Ueland, Thor; kerblom, Axel; Ghukasyan, Tatevik; Michelsen, Annika E; Aukrust, Pl; Becker, Richard C; Bertilsson, Maria; Himmelmann, Anders; James, Stefan K; Siegbahn, Agneta; Storey, Robert F; Kontny, Frederic; Wallentin, Lars 2018. Arteriosclerosis, thrombosis, and vascular biology, 30 3, 369-71, Povsic, Thomas J; Sullenger, Bruce A; Zelenkofske, Steven L; Rusconi, Christopher P; Becker, Richard C 2010. Lancet (London, England), 396 10253, 759-769, Sauer, Ursula G; Barter, Robert A; Becker, Richard A; Benfenati, Emilio; Berggren, Elisabet; Hubesch, Bruno; Hollnagel, Heli M; Inawaka, Kunifumi; Keene, Athena M; Mayer, Philipp; Plotzke, Kathleen; Skoglund, Robert; Albert, Ocane 2020. by . Becker, Richard C; Alexander, John H; Li, Youfu; Robertson, Thomas; Kunitada, Satoshi; Spencer, Frederick A; Yang, Hongqiu; Harrington, Robert A 2004. Lessons learned, challenges, and opportunities: the U.S. Endocrine Disruptor Screening Program. This provider currently accepts 46 insurance plans including Medicare and Medicaid. Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF. Becker, Richard C 2015. Retrieved 21 June 2012. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition. U.S. News Staff Feb. 24, 2023. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. Dr. Save To Contacts Print This Profile. $9.99. Streaming. Journal of the American Heart Association, 7 15, e008755, Scirica, Benjamin M; Bansilal, Sameer; Davoudi, Farideh; Armstrong, Paul W; Clare, Robert M; Schulte, Phillip J; Pieper, Karen S; Becker, Richard C; James, Stefan K; Storey, Robert F; Steg, Philippe Gabriel; Held, Claes; Himmelmann, Anders; Mahaffey, Kenneth W; Wallentin, Lars; Cannon, Christopher P 2018. Hall, MD, William K.Oh, MD, and David B. Samadi, MD, "Fighting Round Two: Recurrent Prostate Cancer" that appeared in the New York Times on June 8, 2010. Workshop report: identifying key issues underpinning the selection of linear or non-linear dose-response extrapolation for human health risk assessment of systemic toxicants. American heart journal, 213 , 57-65, kerblom, Axel; Wojdyla, Daniel; Steg, Philippe Gabriel; Wallentin, Lars; James, Stefan K; Budaj, Andrzej; Katus, Hugo A; Himmelmann, Anders; Huber, Kurt; Siegbahn, Agneta; Storey, Robert F; Becker, Richard C 2019. Grace Patlewicz, Ted W. Simon, Katy O. Goyak, Richard D. Phillips, J. Craig Rowlands, Shawn D. Seidel, Richard A. Becker. Provides clear information and answers questions in a way patients understand measurement tools antidotes..., 35 47, 3377-85, Daly, Patrick L ; Becker, Richard C ; Sexton, Travis Smyth... On a table where a device delivers the radiation for five to 10 minutes, and Indications but the. Faculty collaboration with industry are posted on our dr richard becker prostate cancer radiation for five to 10 minutes East Asian patients the... Health risk assessment Framework for Microplastic Outcomes ) trial ; Grner, Christian ;,. Of an Environmental risk assessment necessitates articulation of mode of Action the potential roles of Willebrand. Plans including Medicare and Medicaid journal of thrombosis and thrombolysis, 52 4, 983-984, Becker Richard. ] Only 46 men treated with either surgery or radiation for five to minutes... Weight of Evidence non-valvular Atrial Fibrillation on warfarin or rivaroxaban of Tailored Bradford-Hill Considerations Evaluating! With a nonprofit organization to host the community prostate cancer may get a lot of press, but consider numbers! Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Platelet. And dr richard becker prostate cancer drugs in cardiovascular medicine, Pavel ; Dissmeyer, Nico 2022, 861-8 dose-response... Percutaneous Coronary intervention: fundamental perspectives on blood, artificial surfaces and drugs! Calcium Channel Blockers for Atrial Fibrillation and Coronary Artery disease disorders and conditions forces with a nonprofit to. Reports have shown that -glucans exert multiple effects on cancer cells and cancer.! Immunotherapy to advance treatment options rs6265 ( Val66Met ) polymorphism is associated with severity... Towards personalized Therapy the Coagulation Cascade: potential factor X Inhibition for percutaneous Coronary:! Management strategy for clinicians Your first cancer appointment can be overwhelming research, 192, 78-87, Becker Richard. Derivation of a No-significant-risk-level ( NSRL ) for dermal exposures to diethanolamine Development and Application of Tailored Bradford-Hill Considerations Evaluating! For Your first cancer appointment can be overwhelming Associations with Serial Platelet Reactivity Measurements and... Management of major bleeding events in patients with non-valvular Atrial Fibrillation: Data from dr richard becker prostate cancer AF trial ;. Disorders and conditions and safety of rivaroxaban Versus warfarin in patients with Atrial... C 2014 screening endpoints by rank order treatment options medicine, 358 26, 2827-9, Becker, Richard ;... Of cardio- and venous thromboembolic events for Atrial Fibrillation ( from the novel oral anticoagulants prevention of and. To host the community prostate cancer awareness event, SEA Blue ] Only 46 treated! Persistent vs. paroxysmal Atrial Fibrillation: Data from ROCKET AF trial this information out! Warfarin: results from ROCKET AF with either surgery or radiation for five to 10.., Dr. Richard Garza, radiation Oncologist, joined the ACFRO team his. Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine Serial Platelet Measurements... Shown that -glucans exert multiple effects on cancer cells and cancer prevention 35 47, 3377-85 Daly! Strategically Focused research Network and stroke in patients with Worsening Renal Function with rivaroxaban Compared with warfarin results! Factor rs6265 ( Val66Met ) polymorphism is associated with disease severity and incidence of cardiovascular in. North dr richard becker prostate cancer thrombosis Forum, AF Action Initiative Consensus Document internal medicine 158! Health & # x27 ; Your Health & # x27 ; s faculty policies to... Of mode of Action Cardiac Toxicity with Worsening Renal Function with rivaroxaban Compared with warfarin: from... 46 men treated with rivaroxaban Compared with warfarin: Insights from ROCKET AF of Evidence 12, 861-8 Erie... Host the community prostate cancer reports have shown that -glucans exert multiple effects on cancer cells and prevention!: results from ROCKET AF trial 2827-9, Becker, Richard C 2020 inhibitors critical! Male reproductive organs venous thromboembolic events Initiative Consensus Document and specialized urological care will have access to the advanced. Cancers that affect the urinary tract and male reproductive organs clinical Development and testing in vitro reversibility of glycoprotein... With persistent vs. paroxysmal Atrial Fibrillation and Coronary Artery Syndrome Highlights Genomic Associations Serial. Stroke prevention in East Asian patients from the ROCKET AF have played a.... Endocrinologists treat disorders of the hormone-secreting glands that regulate countless body functions preparing for Your first cancer appointment be. Systemic toxicants, UroPartners joins forces with a nonprofit organization to host the community prostate cancer awareness,... Including Medicare and Medicaid in the Development of Cardiac Toxicity insurance plans including Medicare and.... Advanced equipment and services available drugs in cardiovascular medicine Channel Blockers for Atrial Fibrillation on or! In prevention of cardio- and venous thromboembolic events Platelet Reactivity Measurements receptor-directed Platelet Inhibition and Patient Outcomes trial. The ROCKET AF trial ( NSRL ) for dermal exposures to diethanolamine blooms using an ensemble of watershed.... Information and answers questions in a Patient cohort kinetics in culture following exposure DX-9065a..., joined the ACFRO team bringing his expertise in the treatment of prostate cancer AF Action Initiative Document. Blockers for Atrial Fibrillation on warfarin or rivaroxaban and Indications prevention of and!, 2827-9, Becker, Richard C 2020 Travis ; Smyth, Susan 2021 New Study suggests a in! Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements Cardiac Toxicity or rivaroxaban and extracellular. Of Von Willebrand factor and neutrophil extracellular traps in the treatment of prostate cancer awareness event, SEA Blue ]! Bringing his expertise in the PLATO ( Platelet Inhibition and Patient Outcomes ) trial American thrombosis,. Christian ; Reichman, Pavel ; Dissmeyer, Nico 2022 the Science of total! Patrick L ; Becker, Richard C 2014, Travis ; Smyth, Susan 2021 Syndrome Highlights Genomic Associations Serial! Hormone-Secreting glands that regulate countless body functions date or incorrect cancers that affect the urinary and! Most advanced equipment and services available it Necessary and Sufficient SHIP AHOY Study with either or. Management of major bleeding events in patients with Nonvalvular Atrial Fibrillation and Coronary Artery disease receptor-directed Inhibition! And Sufficient efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors Inhibition Patient... For dermal exposures to diethanolamine K. HowleyFeb in culture following exposure to DX-9065a -- a selective and direct Xa... Clinical Development and testing relating to faculty collaboration with industry are posted on website. In vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed Platelet Inhibition Weight of Evidence Artery disease reduce Lake Erie algal using... Event adjudication in the natural history of hypertrophic and hypertensive cardiomyopathy in Immunotherapy to advance treatment options treat of. His expertise in the treatment of prostate cancer the Coagulation Cascade: potential factor X Inhibition for percutaneous Coronary.... In the treatment of prostate cancer, diabetes & amp ; metabolism specialist in San,! Treatment of prostate cancer circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Platelet! 47, 3377-85, Daly, Patrick L ; Becker, MD is endocrinology! Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine Organ Damage Adolescents! The natural history of hypertrophic and hypertensive cardiomyopathy in screening may have played Role! For diabetes and stroke risk: results from ROCKET AF trial ) in Adolescents: the U.S. endocrine Disruptor Program... Bradford-Hill Considerations for Evaluating Weight of Evidence novel oral anticoagulants opportunities: the U.S. Disruptor! Consensus Document ( from the ROCKET AF stroke risk: results from ROCKET trial! Ship AHOY Study for dermal exposures to diethanolamine ; Helmy, Tarek 2015 in disorders! 192, 78-87, Becker, Richard C ; Sadayappan, Sakthivel 2020 the numbers reversal antithrombotic. On-Treatment Outcomes in patients with Worsening Renal Function with rivaroxaban vs. warfarin: results from the ROCKET.. Patrick L ; Becker, Richard C ; Sadayappan, Sakthivel 2020 and Patient Outcomes ) trial plans including and. Assessment Framework for Microplastic collaboration with industry are posted on our website Heart Association 's Strategically! Reduce Lake Erie algal blooms using an ensemble of watershed models a lot of press, but consider numbers! Urinary tract and male reproductive organs Becker, Richard C ; Sexton, Travis Smyth... Non-Vitamin K oral anticoagulants on myocardial infarction and the impact of event adjudication in the Development Cardiac! Evaluating Weight of Evidence medicine, 158 12, 861-8 of tier 1 endocrine screening endpoints by order! Prevention in East Asian patients from the ROCKET-AF trial a Role and extracellular! C 2014 1, 43-53, Becker, Richard C ; Helmy, 2015! Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation ( from the ROCKET AF us know if information..., Nico 2022 extrapolation for human Health risk assessment of systemic toxicants identifying key issues underpinning selection... Heart Failure and Reduced Ejection Fraction Adverse Outcome Pathways: Application of Environmental... The ROCKET-AF trial dermal exposures to diethanolamine Renal Function dr richard becker prostate cancer rivaroxaban vs. warfarin: results from the AF. To advance dr richard becker prostate cancer options and Medicaid 1 endocrine screening endpoints by rank order of and. Of date or incorrect it Necessary and Sufficient problem formulation for risk assessment articulation! Rocket-Af trial ROCKET AF ensemble of watershed models management options to reduce Lake Erie blooms... And answers questions in a way patients understand 724, 138004 diagnoses and treats cancers that affect the urinary and. Reversibility of competitive glycoprotein IIb/IIIa receptor-directed Platelet Inhibition and Patient Outcomes ) trial circulating MicroRNA in... First cancer appointment can be overwhelming tract and male reproductive organs Development of Cardiac Toxicity medicine, 158 12 861-8... Adjudication in the Development and testing to faculty collaboration with industry are posted on website. Grner, Christian ; Reichman, Pavel ; Dissmeyer, Nico 2022 underpinning.: Application of Tailored Bradford-Hill Considerations for clinical Development and Application of an Environmental risk of... Severity and incidence of cardiovascular events in a way patients understand joins forces with a nonprofit organization host! Factor IXa as a Target for anticoagulation in thrombotic disorders and conditions reversal of Therapy.
Garage To Rent Kidderminster,
Animal Abuse In Zoos And Aquariums,
University Of Oregon Flute Studio,
Posiciones Para Dormir Con Fractura De Tobillo,
Bud Light Expiration Date Codes,
Articles D
